Subtype
Uterine Neoplasm
CI-CAN-00004208Explore in graph →
Non-malignant925 active trials7 approved drugs44 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004208Explore in graph →
Clinical trials
3,823 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03551028 | HPV DNA Testing Through Mobile Mammography Unit | completed | N/A | 33 | University of VirginiaOTHER | 1 | Nov 4, 2024 | clinicaltrials |
| NCT05227651 | AK104 in Neoadjuvant Treatment of Cervical Cancer | completed | Phase 2 | 14 | AkesoINDUSTRY | 1 | Nov 1, 2024 | clinicaltrials |
| NCT03308591 |
| completed |
| Phase 3 |
| 774 |
| Huazhong University of Science and TechnologyOTHER |
| 1 |
| Oct 31, 2024 |
| clinicaltrials |
| NCT01600040 | Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix | completed | N/A | 22 | Massachusetts General HospitalOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT02040142 | HIPEC for Peritoneal Carcinomatosis | completed | Phase 2 | 51 | Albert Einstein College of MedicineOTHER | 1 | Oct 24, 2024 | clinicaltrials |
| NCT03345485 | Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.(EDO-S101) | completed | Phase 1 / Phase 2 | 71 | Mundipharma Research LimitedINDUSTRY | 5 | Oct 21, 2024 | clinicaltrials |
| NCT05959564 | A Chatbot Intervention for Reducing HPV Vaccine Hesitancy | completed | N/A | 456 | University of Maryland, College ParkOTHER | 1 | Oct 21, 2024 | clinicaltrials |
| NCT03721978 | REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) | completed | Phase 3 | 203 | Inovio PharmaceuticalsINDUSTRY | 10 | Oct 17, 2024 | clinicaltrials |
| NCT06644677 | Third-Generation Nanopore HPV Integration Site for Precise Prediction of Cervical Cancer Prognosis | completed | — | 200 | Peking Union Medical College HospitalOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT06313268 | Safety of Effivia®, a Bevacizumab Biosimilar | completed | — | 83 | Laboratorios LiomontINDUSTRY | 1 | Oct 10, 2024 | clinicaltrials |
| NCT06623916 | Strain-elastography in Endometrial Cancer | completed | — | 63 | Alper seyhanOTHER | 1 | Oct 2, 2024 | clinicaltrials |
| NCT03648489 | Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)(DICE) | completed | Phase 2 | 134 | Imperial College LondonOTHER | 2 | Sep 20, 2024 | clinicaltrials |
| NCT05344950 | Connecting Audio and Radio Sensing Systems to Improve Care at Home(AURA) | completed | — | 13 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05518812 | Carboprost (Hemabate) for Fibroid Resection | completed | Early Phase 1 | 19 | Northwestern UniversityOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT02431676 | Survivorship Promotion In Reducing IGF-1 Trial(SPIRIT) | completed | Phase 2 | 121 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT05783167 | Self-collected Vaginal and Urine Samples in HIV-positive Women | completed | — | 502 | University of AarhusOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT05362955 | 5-fluorouracil Following Cervical Intraepithelial Neoplasia Treatment Among HIV-positive Women in East Africa | completed | Phase 1 | 12 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Aug 23, 2024 | clinicaltrials |
| NCT03766672 | Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique(ENDO-NGS-MQ) | completed | — | 30 | University Hospital Center of MartiniqueOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT01164735 | Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer | completed | — | 169 | Gynecologic Oncology GroupNETWORK | 1 | Aug 14, 2024 | clinicaltrials |
| NCT01198171 | Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer | completed | — | 243 | Gynecologic Oncology GroupNETWORK | 1 | Aug 14, 2024 | clinicaltrials |
| NCT01344837 | Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer | completed | — | 360 | Gynecologic Oncology GroupNETWORK | 1 | Aug 14, 2024 | clinicaltrials |
| NCT02009579 | ENGOT-cx1/BGOG-cx1: 3 Weekly Carboplatin/Paclitaxel With or Without Nintedanib in Cervix Cancer | completed | Phase 2 | 120 | Belgian Gynaecological Oncology GroupOTHER | 4 | Aug 7, 2024 | clinicaltrials |
| NCT03133286 | Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)(RADIANT) | completed | — | 16 | DxTerity DiagnosticsINDUSTRY | 1 | Aug 7, 2024 | clinicaltrials |
| NCT06524934 | Virtual Reality's Role in See&Treat Hysteroscopy | completed | N/A | 116 | Federico II UniversityOTHER | 1 | Jul 29, 2024 | clinicaltrials |
| NCT02020707 | Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers | completed | Phase 1 | 43 | Mayo ClinicOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT03830866 | Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)(CALLA) | completed | Phase 3 | 770 | AstraZenecaINDUSTRY | 15 | Jul 26, 2024 | clinicaltrials |
| NCT06518070 | Results Comparison of Cervical Cancer Early Detection Using Cerviray With VIA Test | completed | — | 44 | Universitas PadjadjaranOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT02501954 | Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol | completed | Phase 3 | 48 | Women's Cancer Care Associates, LLCOTHER | 2 | Jul 23, 2024 | clinicaltrials |
| NCT03218436 | Physical Cold Atmospheric Plasma for the Treatment of Cervical Intraepithelial Neoplasia(CAPCIN) | completed | N/A | 63 | University Hospital TuebingenOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT05340322 | Identification and Treatment of Cervical Abnormalities in Perú Through Integration of Pocket Colposcopy and Telemedicine | completed | N/A | 503 | Duke UniversityOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT04570839 | COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors. | completed | Phase 1 / Phase 2 | 48 | Compugen LtdINDUSTRY | 1 | Jul 18, 2024 | clinicaltrials |
| NCT04045652 | Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan Women | completed | — | 223 | Indiana UniversityOTHER | 3 | Jul 17, 2024 | clinicaltrials |
| NCT04257045 | Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives | completed | — | 46 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 12, 2024 | clinicaltrials |
| NCT05662683 | The Effect of Virtual Reality and Distraction Cards on Pain(Pap-Smear) | completed | N/A | 132 | Turkish Ministry of Health, Kahramanmaras Provincial Health DirectorateOTHER_GOV | 1 | Jul 9, 2024 | clinicaltrials |
| NCT03752398 | A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)(DUET-3) | completed | Phase 1 | 198 | Xencor, Inc.INDUSTRY | 1 | Jul 5, 2024 | clinicaltrials |
| NCT06489171 | Research on Laparoscopic Fertility-Sparing Surgery in Early-Stage Cervical Cancer | completed | — | 132 | Peking Union Medical College HospitalOTHER | 0 | Jul 5, 2024 | clinicaltrials |
| NCT00026663 | Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance | completed | — | 86 | National Cancer Institute (NCI)NIH | 1 | Jul 1, 2024 | clinicaltrials |
| NCT05538572 | A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors | completed | Phase 1 | 22 | Prelude TherapeuticsINDUSTRY | 2 | Jul 1, 2024 | clinicaltrials |
| NCT05578820 | Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid | completed | Phase 1 | 21 | Gene Surgery LLCINDUSTRY | 1 | Jul 1, 2024 | clinicaltrials |
| NCT03751124 | Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | completed | Phase 3 | 229 | Myovant Sciences GmbHINDUSTRY | 8 | Jun 25, 2024 | clinicaltrials |
| NCT04312178 | Combined Incentive Actions, Focusing on Primary Care, to Improve Cervical Cancer Screening in Women Residing in Socio-economically Disadvantaged and Untracked Geographical Areas: a Hybrid Efficacy and Implementation Trial(RESISTE) | completed | N/A | 10,446 | Centre Hospitalier Universitaire DijonOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT04799639 | Efficacy and Toxicity of Paclitaxel, Cisplatin Combined With Sindilimab in NACT for Locally Advanced Cervical Cancer | completed | Phase 2 | 47 | Sun Yat-sen UniversityOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT05990270 | The Effect of Education Given to Women on Cervical Cancer on Knowledge, Attitude and Belief(EEWCCKAB) | completed | N/A | 102 | Kahramanmaras Sutcu Imam UniversityOTHER | 1 | Jun 24, 2024 | clinicaltrials |
| NCT06440382 | Scottish Cervical Screening and Ethnicity Project(SCREEN) | completed | — | 600,000 | University of EdinburghOTHER | 1 | Jun 3, 2024 | clinicaltrials |
| NCT04205630 | SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma | completed | Phase 2 | 64 | Byondis B.V.INDUSTRY | 7 | May 30, 2024 | clinicaltrials |
| NCT03926936 | FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study(FUCHSia) | completed | Phase 2 | 17 | Frederic AmantOTHER | 2 | May 28, 2024 | clinicaltrials |
| NCT03629756 | A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies | completed | Phase 1 | 48 | Arcus Biosciences, Inc.INDUSTRY | 2 | May 24, 2024 | clinicaltrials |
| NCT05517590 | Intravenous Tranexamic Acid and Intramyometrial Desmopressin Effect on Blood Loss During Laparoscopic Myomectomy. | completed | N/A | 102 | Acibadem UniversityOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT03514459 | Testing an Implementation Science Tool to Increase Cervical Cancer Screening in Mombasa, Kenya | completed | N/A | 20 | University of WashingtonOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT02831556 | Point of Care 3D Ultrasound for Various Applications: A Pilot Study | completed | — | 174 | Duke UniversityOTHER | 1 | May 21, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Nov 4, 2024source: clinicaltrials